Paraneoplastic Antigen Ma2 Autoantibodies as Specific Blood Biomarkers for Detection of Early Recurrence of Small Intestine Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Paraneoplastic Antigen Ma2 Autoantibodies as Specific Blood Biomarkers for Detection of Early Recurrence of Small Intestine Neuroendocrine Tumors

Published:2010-12-30 Issue:12 Volume:5 Page:e16010
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cui Tao,Hurtig Monica,Elgue Graciela,Li Su-Chen,Veronesi Giulia,Essaghir Ahmed,Demoulin Jean-Baptiste,Pelosi Giuseppe,Alimohammadi Mohammad,Öberg Kjell,Giandomenico Valeria

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors).;K Oberg;Curr Opin Endocrinol Diabetes Obes,2009

2. Gastroenteropancreatic neuroendocrine tumours.;IM Modlin;Lancet Oncol,2008

3. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.;DS Klimstra;Am J Surg Pathol,2010

4. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.;G Kloppel;Ann N Y Acad Sci,2004

5. Carcinoid tumors: development of our knowledge.;W Creutzfeldt;World J Surg,1996

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives;Military Medical Research;2024-06-04

2. Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles;European Journal of Neurology;2024-03-11

3. PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome;Cell;2024-02

4. Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders;Handbook of Clinical Neurology;2024

5. Emerging Immunotherapeutic and Diagnostic Modalities in Carcinoid Tumors;Molecules;2023-02-22